Bg pattern

ROCURONIUM KALCEKS 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ROCURONIUM KALCEKS 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Rocuronio Kalceks 10mg/ml solution for injection and infusion EFG

Rocuronium bromide

Read all of this leaflet carefully before you are given this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your anesthesiologist or another doctor.
  • If you experience any side effects, talk to your anesthesiologist or another doctor, even if they are not mentioned in this leaflet. See section 4.

Contents of the package leaflet

  1. What is Rocuronio Kalceks and what is it used for
  2. What you need to know before you are given Rocuronio Kalceks
  3. How Rocuronio Kalceks is given to you
  4. Possible side effects
  5. Storage of Rocuronio Kalceks
  6. Package contents and further information

1. What is Rocuronio Kalceks and what is it used for

Rocuronio Kalceks belongs to a group of medicines called muscle relaxants.

Muscle relaxants are used during an operation as part of general anesthesia. When you undergo an operation, your muscles must be completely relaxed. This makes the operation easier for the surgeon.

Rocuronio Kalceks can be used if you are receiving anesthesia to facilitate the insertion of a tube into your trachea for mechanical ventilation (mechanical assistance with breathing).

Rocuronio Kalceks can also be used in the intensive care unit to keep your muscles relaxed.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you are given Rocuronio Kalceks

Rocuronio Kalceks must not be given to you:

  • if you are allergic to rocuronium or any of the other ingredients of this medicine (listed in section 6).

Tell your anesthesiologist if this applies to you.

Warnings and precautions

Tell your anesthesiologist before you are given this medicine:

  • if you are allergic to any muscle relaxant
  • if you have had kidney, heart, vascular, liver, gallbladder, or bile duct disease
  • if you have had diseases that affect the nerves and muscles
  • if you have fluid retention (edema)
  • if you have a history of malignant hyperthermia (sudden fever with palpitations, rapid breathing, and muscle stiffness, pain, and/or weakness).

Tell your anesthesiologist if any of the above situations apply to you.

Certain conditions may influence the effects of Rocuronio Kalceks, for example:

  • low calcium levels in the blood
  • low potassium levels in the blood
  • high magnesium levels in the blood
  • low protein levels in the blood
  • too much carbon dioxide in the blood
  • excessive water loss from the body, for example, due to illness, diarrhea, or sweating
  • excessive breathing that causes insufficient carbon dioxide in the blood (alkalosis)
  • poor general health
  • burns
  • being severely overweight (obesity)
  • very low body temperature (hypothermia).

If you have any of these conditions, your anesthesiologist will take them into account when deciding the correct dose of Rocuronio Kalceks for you.

Children and elderly

Rocuronio Kalceks can be used in children (newborns and adolescents) and elderly patients, but your anesthesiologist must evaluate your medical history first.

Other medicines and Rocuronio Kalceks

Tell your anesthesiologist or doctor if you are taking, have recently taken, or might take any other medicines. This includes medicines or herbal remedies bought without a prescription. Rocuronio Kalceks may affect other medicines or be affected by them.

Medicines that increase the effect of Rocuronio Kalceks:

  • certain antibiotics
  • certain medicines used for heart disease or high blood pressure (diuretics, calcium channel blockers, beta blockers, and quinidine)
  • certain anti-inflammatory medicines (corticosteroids)
  • certain medicines used to treat manic depressive syndrome (bipolar disorder)
  • magnesium salts
  • certain medicines used to treat malaria.

Medicines that decrease the effect of Rocuronio Kalceks:

  • certain medicines used to treat epilepsy
  • calcium chloride and potassium chloride
  • certain protease inhibitors called gabexate and ulinastatin.

Additionally, you may be given other medicines before or during surgery that may alter the effects of Rocuronio Kalceks. These include certain anesthetics, other muscle relaxants, medicines such as phenytoin, and medicines that reverse the effect of Rocuronio Kalceks. Rocuronio Kalceks may make certain anesthetics work more quickly. Your anesthesiologist will take this into account when deciding the correct dose of Rocuronio Kalceks for you.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or anesthesiologist before you are given this medicine.

Pregnancy

No adverse effects have been observed in animal studies. However, there are no clinical data on the use of rocuronium bromide in pregnant women. Therefore, rocuronium bromide should be used with caution in pregnant women.

Cesarean section

A doctor will decide whether rocuronium bromide can be used during a cesarean section. The use of rocuronium bromide during a cesarean section has been shown to be safe with a dose of 0.6 mg/kg body weight and has no adverse effects on the baby.

Breastfeeding

Breastfeeding should be discontinued 6 hours after administration of this medicine.

Driving and using machines

Do not drive or use machines until you are told it is safe to do so. Because Rocuronio Kalceks is given as part of general anesthesia, you may feel tired, weak, or dizzy for some time after. Your anesthesiologist can advise you on the likely duration of these effects.

Rocuronio Kalceks contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per 1 ml, which is essentially "sodium-free".

3. How Rocuronio Kalceks is given to you

Dose

Your anesthesiologist will calculate the dose of Rocuronio Kalceks you need based on:

  • the type of anesthetic,
  • the expected duration of the operation,
  • other medicines you are taking,
  • your state of health.

The usual dose is 0.6 mg per kg body weight and its effect lasts for 30 to 40 minutes.

How Rocuronio Kalceks is given to you

Your anesthesiologist will give you Rocuronio Kalceks by injection into a vein, either as single injections or as a continuous infusion (with a drip).

If you are given too much Rocuronio Kalceks

Because your anesthesiologist will be monitoring your condition carefully, it is unlikely that you will be given too much Rocuronio Kalceks. However, if this happens, your anesthesiologist will keep you breathing artificially (with a respirator) until you can breathe on your own again. You will remain asleep while this happens.

If you have any further questions on the use of this medicine, ask your doctor or anesthesiologist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. If these side effects occur while you are under anesthesia, your anesthesiologist will see them and treat them.

Uncommon side effects(may affect up to 1 in 100 people)

  • the medicine is too effective, not effective enough
  • the medicine acts for longer than expected
  • decrease in blood pressure
  • increase in heart rate
  • pain at the injection site.

Rare side effects(may affect up to 1 in 10,000 people)

  • allergic reactions (hypersensitivity) (such as difficulty breathing, circulatory collapse, and shock)
  • chest tightness
  • muscle weakness
  • swelling, rash, or redness of the skin.

Frequency not known(cannot be estimated from the available data):

  • allergic spasm and severe coronary artery spasms (Kounis syndrome) causing chest pain (angina) or heart attack (myocardial infarction)
  • dilated pupils (mydriasis) or fixed pupils that do not change size with light or other stimuli.

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your anesthesiologist or another doctor.

Reporting of side effects

If you experience any side effects, talk to your anesthesiologist or another doctor. Even if it is possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines and Healthcare Products Agency (AEMPS) at www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Rocuronio Kalceks

Keep this medicine out of the sight and reach of children.

Store in a refrigerator (2°C8°C). Do not freeze.

Store below 25°C:

Rocuronium bromide can also be stored below 25°Cfor a maximum period of 12 weeks, after which it must be discarded. The product must not be returned to the refrigerator once it has been stored at room temperature. The storage period must not exceed the shelf-life.

After dilution:

After dilution with intravenous fluids, the chemical and physical stability in use has been demonstrated for 72 hours at 30°C.

From a microbiological point of view, the medicine should be used immediately. If not used immediately, the in-use storage times and conditions are the responsibility of the user and would normally not be longer than 24 hours at a temperature of 2 to 8°C, unless the dilution has been made in controlled and validated aseptic conditions.

Do not use this medicine if you notice visible signs of deterioration (e.g. particles).

Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date is the last day of the month shown.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Package contents and further information

Composition of Rocuronio Kalceks

  • The active substance is rocuronium bromide.

1 ml of solution contains 10 mg of rocuronium bromide.

Each 5 ml vial of solution contains 50 mg of rocuronium bromide.

  • The other ingredients are sodium chloride; sodium acetate trihydrate; glacial acetic acid (for pH adjustment); water for injections.

Appearance and package contents

Clear, colorless or yellowish solution for injection and infusion.

Package size:

Rocuronio Kalceks is available in packs of 10 vials with 5 ml of solution.

Marketing authorization holder and manufacturer

AS KALCEKS

Krustpils iela 71E, Riga, LV-1057, Latvia

Phone: +371 67083320

Email: [email protected]

For further information about this medicine, please contact the local representative of the marketing authorization holder

EVER Pharma Therapeutics Spain SL

C/ Toledo 170

28005 Madrid

Spain

This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:

Czech Republic, Estonia, Norway Rocuronium bromide Kalceks

Austria Rocuronium Kalceks 10 mg/ml Injektions-/Infusionslösung

Croatia Rokuronijev bromid Kalceks 10 mg/ml otopina za injekciju/infuziju

France ROCURONIUM KALCEKS 10 mg/mL, solution injectable/pour perfusion

Hungary Rocuronium Kalceks 10 mg/ml oldatos injekció vagy infúzió

Ireland Rocuronium bromide 10 mg/ml solution for injection/infusion

Latvia Rocuronium bromide Kalceks 10 mg/ml šķidums injekcijām/infūzijām

Lithuania Rocuronium bromide Kalceks 10 mg/ml injekcinis ar infuzinis tirpalas

Netherlands Rocuronium Kalceks 10 mg/ml oplossing voor injectie/infusie

Poland Rocuronium Kalceks

Slovakia Rocuronium bromide Kalceks 10 mg/ml injekčný/infúzny roztok

Slovenia Rokuronijev bromid Kalceks 10 mg/ml raztopina za injiciranje/infundiranje

Spain Rocuronio Kalceks 10 mg/ml solución inyectable y para perfusión EFG

United Kingdom (Northern Ireland) Rocuronium bromide 10 mg/ml solution for injection/infusion

Date of last revision of this leaflet June 2023

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es)

Online doctors for ROCURONIUM KALCEKS 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION

Discuss questions about ROCURONIUM KALCEKS 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ROCURONIUM KALCEKS 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION?
ROCURONIUM KALCEKS 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ROCURONIUM KALCEKS 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION?
The active ingredient in ROCURONIUM KALCEKS 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION is rocuronium bromide. This information helps identify medicines with the same composition but different brand names.
Who manufactures ROCURONIUM KALCEKS 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION?
ROCURONIUM KALCEKS 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION is manufactured by Kalceks As. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ROCURONIUM KALCEKS 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ROCURONIUM KALCEKS 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ROCURONIUM KALCEKS 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION?
Other medicines with the same active substance (rocuronium bromide) include ESMERON 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION, ROCURONIUM AGUETTANT 10 mg/mL Injectable Solution in Pre-filled Syringe, ROCURONIUM B. BRAUN 10 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media